All Stories Page

Why We're MADE FOR THIS

Learn what we're doing to transform health care, prepare the next generation of leaders, and solve the world's greatest medical challenges.

Stories

Beating the Odds
Nicole McGuinness was 29 in December 2015 when she woke up already an hour late for her government relations job. She had blood on her shirt, and her tongue was swollen.
Bursting the Bubble
A new clinical program gets Duke medical students off campus and into the community to serve.
Duke Nursing Students Make a Difference in Guatemala
As students at Duke University School of Nursing, Lindsay Salisbury and Shelby Strockbine entered their third semester with a new perspective on the importance of global health and their roles as future nurses.
‘Like a Tsunami’
When reports early last winter indicated that a mysterious new infectious disease had broken out of its point of origin in Wuhan, China, Charles Lucore, MD’83, P’17, MBA, began to prepare for its possible arrival in New York.
A Long Struggle

Eric Dziuban, MD’07, the Centers for Disease Control and Prevention’s country director for the southwest African nation of Namibia, was enjoying a weekend at the coast with his family when the call came. A Romanian couple who had recently arrived in the Namibian capital of Windhoek from Spain had fallen ill. Tests confirmed everyone’s fear: COVID-19 had finally come to Namibia.

The Drug Guy Changes Course
Breast cancer researcher Donald McDonnell, PhD, met his wife, Mary, in Maine for a week of vaca­tion. Sitting at a secluded inn on Anne’s Point, McDon­nell, Coleader of the Women’s Cancer Research Program at the Duke Cancer Institute, couldn’t stop thinking about what he had heard at a meeting.
A Constant Presence
In 2016, Duke employee Brandy Chieco was a new mom with a three-month-old baby boy when her own mom, Brenda Brooks, was diagnosed with synovial sarcoma, which tends to arise in the joints.
A Detour Into Melanoma
Postdoctoral Fellow Binita Chakraborty, PhD was intrigued: in published analyses of large numbers of patients with melanoma (skin cancer) treated with an immunotherapy that is becoming standard of care, the treatment worked better in men than in women.